AVALO THERAPEUTICS INC AVTX
COM NEW · Common Stock · CUSIP 05338F306
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersWayne, PA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 1.0m as of 2024-08-05, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $12.47.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2023 | 13 |
| Q1 2024 | 19 |
| Q2 2024 | 22 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2024 | 12 | 5 |
| Q2 2024 | 11 | 8 |
Biggest buyers
| Logos Global Management LP | New | +539.1k |
| Sio Capital Management, LLC | Added | +61.3k |
| Commodore Capital LP | New | +40.0k |
| Affinity Asset Advisors, LLC | Added | +35.0k |
| VANGUARD GROUP INC | New | +10.4k |
| Ikarian Capital, LLC | Added | +8.1k |
| BANK OF AMERICA CORP /DE/ | New | +5.6k |
| ROYAL BANK OF CANADA | Added | +268 |
| FMR LLC | New | +2 |
| Key Financial Inc | New | +1 |
Biggest sellers
| ADAR1 Capital Management, LLC | Sold out | -6.0k |
| UBS Group AG | Reduced | -4.1k |
| NATIXIS | Sold out | -2.5k |
| BlackRock Inc. | Reduced | -1.8k |
| Tower Research Capital LLC (TRC) | Sold out | -1.6k |
| MORGAN STANLEY | Reduced | -107 |
| WELLS FARGO & COMPANY/MN | Reduced | -7 |
| Towne Trust Company, N.A | Sold out | -1 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| FMR LLC 13G · institution +1.1 pts · filed 2026-08-07 | 10.8% |
| Commodore Capital LP 13G · passive investor new · filed 2026-06-18 | 9.9% |
| TCG Crossover GP II, LLC 13G · passive investor new · filed 2026-05-12 | 7.9% |
| Deep Track Capital, LP 13G · passive investor +1.1 pts · filed 2026-08-14 | 6.9% |
| BlackRock, Inc. 13G · institution new · filed 2026-07-27 | 6.5% |
| RA CAPITAL MANAGEMENT, L.P. 13G · passive investor -3.6 pts · filed 2026-08-14 | 6.3% |
| Caligan Partners LP 13G · institution -1.3 pts · filed 2026-08-14 | 5.9% |
| Affinity Asset Advisors, LLC 13G · institution no change · filed 2026-08-13 | 5.5% |
| STATE STREET CORP 13G · institution new · filed 2026-08-07 | 5.5% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor -4.7 pts · filed 2026-08-14 | 5.3% |
| Point72 Asset Management, L.P. 13G · passive investor +1.7 pts · filed 2026-05-26 | 5.2% |
Fell to 5% or below in the last year: T. Rowe Price Investment Management, Inc. (0.0%, 2026-08-14), Nantahala Capital Management, LLC (3.5%, 2026-08-14), Avoro Capital Advisors LLC (4.4%, 2026-08-14), MILLENNIUM MANAGEMENT LLC (0.0%, 2026-07-06), Logos Global Management LP (3.2%, 2026-05-15), ORBIMED ADVISORS LLC (2.1%, 2026-05-15), BALYASNY ASSET MANAGEMENT L.P. (2.4%, 2026-02-17), SILVERARC CAPITAL MANAGEMENT, LLC (2.8%, 2026-02-10), VANGUARD GROUP INC (4.4%, 2026-01-30)
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 1 | $9.2k | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 2 | $15.4k | 0 | — | — |
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| Logos Global Management LP 0.39% of their portfolio | 539.1k $6.7m | New |
| Sio Capital Management, LLC 0.34% of their portfolio | 71.5k $891.1k | Added +61.3k |
| Ikarian Capital, LLC 0.21% of their portfolio | 54.7k $682.5k | Added +8.1k |
| Affinity Asset Advisors, LLC 0.09% of their portfolio | 45.0k $561.1k | Added +35.0k |
| Commodore Capital LP 0.03% of their portfolio | 40.0k $498.8k | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 10.4k $129.3k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 5.6k $69.8k | New |
| UBS Group AG 0.00% of their portfolio | 3.6k $44.7k | Reduced -4.1k |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 590 $7.0k | Added +268 |
| Banque Cantonale Vaudoise 0.00% of their portfolio | 338 $4.0k | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 329 $4.1k | Reduced -1.8k |
| MORGAN STANLEY 0.00% of their portfolio | 10 $124 | Reduced -107 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 4 $50 | Unchanged |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 4 $50 | Unchanged |
| FMR LLC 0.00% of their portfolio | 2 $25 | New |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 2 $25 | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 2 $24 | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 1 $12 | Reduced -7 |
| Parallel Advisors, LLC 0.00% of their portfolio | 1 $12 | Unchanged |
| Key Financial Inc 0.00% of their portfolio | 1 $12 | New |
| Activest Wealth Management 0.00% of their portfolio | 1 $12 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |